However, the source of this inflammation needs to be investigated further
This in turn weakens the skin barrier and applying ceramides topically has been shown to replenish what's been lost to restore barrier function
The first generation of GLP-1 therapies exhibit reduced susceptibility to enzymatic degradation, while providing effective glucose control, improved -cell function, body weight loss and decreased systolic blood pressure in patients with T2D (Meier, 2012) The newly developed incretin mimetics, including albiglutide, dulaglutide and semaglutide, are designed to have extended pharmacokinetic profiles and efficacy suitable once-weekly administration
GLP-1Rs are found on various cell types involved in psoriasis, such as macrophages, monocytes, T cells, and keratinocytes [5, 197, 198]